Member access

4-Traders Homepage  >  Shares  >  Xetra  >  MorphoSys AG    MOR   DE0006632003

MORPHOSYS AG (MOR)

44
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
05/22/2015 05/26/2015 05/27/2015 05/28/2015 05/29/2015 Date
68.59(c) 67.71(c) 68.05(c) 69(c) 66.84(c) Last
79 161 97 388 76 611 154 178 127 603 Volume
+1.31% -1.28% +0.50% +1.40% -3.13% Change
More quotes
Financials (€)
Sales 2015 105 M
EBIT 2015 5,23 M
Net income 2015 -0,51 M
Finance 2015 91,3 M
Yield 2015 -
Sales 2016 59,2 M
EBIT 2016 12,5 M
Net income 2016 5,79 M
Finance 2016 270 M
Yield 2016 -
PER 2015 180,36
PER 2016 255,41
EV / Sales 2015 16,0x
EV / Sales 2016 25,3x
Capitalization 1 769 M
More Financials
Company
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications.It operates through the following segments: Partnered Discovery, Proprietary Development, and AbD Serotec.The Partnered Discovery segment involves technologies for the generation of human... 
Sector
Biotechnology & Medical Research
Calendar
05/30 | 09:00amPresentation
More about the company
Surperformance© ratings of MorphoSys AG
Trading Rating : Investor Rating :
More Ratings
Latest news on MORPHOSYS AG
05/29 MORPHOSYS : to Present at Five Upcoming Conferences
05/22 MORPHOSYS : to Present Data on Proprietary Programs at 20th Congress of the Euro..
05/21 MorphoSys to Present Data on Proprietary Programs at 20th Congress of the Eur..
05/21 MORPHOSYS : to Present Data on Proprietary Programs at 20th Congress of the Euro..
05/13 MORPHOSYS : to Present Data on Proprietary Programs at American Society of Clini..
05/13 MORPHOSYS : to Present at Two Upcoming Investor Conferences
05/12 MORPHOSYS : to Present at Two Upcoming Investor Conferences
05/08 MORPHOSYS : Acquires Peptide Therapeutic Company Lanthio Pharma
More news
Sector news : Biotechnology & Medical Research - NEC
05/29 GENMAB A/S : Total Number of Voting Rights and Total Share Capital
05/29 ALKERMES : to Present Clinical Data on ALKS 8700 at Annual Meeting of the Consor..
05/29 UNITED THERAPEUTICS : To Present At The Jefferies 2015 Global Healthcare Confere..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/05 MorphoSys's (MPSYF) CEO Seth Fischer on Q1 2015 Results - Earnings Call Trans..
04/17 CELGENE : A Pre-Earnings Discussion Based On Recent News
02/26 MorphoSys' (MPSYF) CEO Simon Moroney on Q4 2014 Results - Earnings Call Trans..


Comments 
Advertisement
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MOR | DE0006632003 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions